Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United Therapeutics
Biotech
United Therapeutics' phase 3 win tees up filing to challenge J&J
United linked a once-daily drug candidate to a 55% drop in the risk of clinical worsening, setting the company up to seek FDA approval this year.
Nick Paul Taylor
Mar 2, 2026 10:40am
United Therapeutics' temporary liver shows promise in trial
Jan 27, 2026 9:00am
eGenesis announces 2nd pig kidney transplant success
Feb 7, 2025 2:10pm
United Therapeutics buys Miromatrix in $91M xenotransplant deal
Oct 30, 2023 10:45am
Revivicor sees 61 days' function in kidney+thymus xenotransplant
Sep 25, 2023 9:45am
New Fair Inclusion score rates cancer clinical trial diversity
Jan 5, 2023 9:25am
